Abstract: Recent progress in our knowledge of gene expression systems provides evidence that many industrial chemicals affect the transcriptional machineries directly or indirectly, and gene expression is now recognized as one of the main targets of many chemicals. In view of the increasing number of man-made chemicals, it is therefore necessary to establish a reliable gene expression assay with rapidity and high sensitivity. Among various gene expression assays, the so-called reporter assay is now accepted as a suitable tool to assess hazardous effects of chemicals on gene expression. This article focuses on the principle and applications of the reporter assay in research on endocrine disrupters.
Introduction
The gene expression system is now recognized as an important cellular target of the detrimental effects of chemicals. This notion has been established largely through the previous investigations of endocrine disrupters. A wide variety of natural and man-made chemicals are now known to act as agonists/antagonists of estrogen and androgen receptors, which modulate gene expression by mimicking the actions of natural hormones 1) . These chemicals include industrially relevant plasticizers (e.g., bisphenol A), surfactants (e.g., alkylphenol ethoxylates, alkylphenols ) and heavy metals (e.g., cadmium), and can possibly lead to disruption of reproductive development and an increased incidence of hormone-dependent cancers [2] [3] [4] [5] [6] [7] . The aryl hydrocarbon receptor (AhR) is another example known to be involved in the expression of chemical toxicity. AhR is a transcription factor, to which halogenated aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) bind, and induces many proteins including cytochrome P450 enzymes 8) . Targeted disruption of the AhR gene has demonstrated that some of the toxic effects of TCDD are apparently mediated by AhR 9) . Other than direct interaction with transcription machineries, chemicals are also known to affect gene expression indirectly. For instance, freshly fractured silica reportedly causes activation of transcription factor AP-1 (activator protein-1) that can induce gene expression relevant to cell proliferation and carcinogenesis 10) . This AP-1 activation is probably mediated through the signal transduction pathway involving p38 mitogen activated protein kinase and extracellular signal-regulated protein kinases. In view of these examples, it seems necessary to establish a high-throughput assay for chemicals, which is commonly applicable to a variety of gene expression systems.
Regulation of transcription is a process involving multiple protein factors that cooperate to maintain a proper level of gene expression. For example, protein factors, termed coactivators and corepressors, are often recruited by many transcription factors to enhance or depress transcription. In addition, if a signal transduction pathway is involved in a Industrial Health 2002, 40, 113-120 gene expression system, the activities of various protein kinases are important determinants for initiation of the transcription. Therefore, a preferable assay for assessing effects of chemicals on gene expression is to measure the transcriptional activity as an end point of multiple intracellular processes. At present, the so-called reporter assay seems suitable for such a purpose, because its feasibility and utility have been demonstrated during the investigations of endocrine disrupters. This review article presents an overview of the mechanism of transcriptional activation via steroid hormone receptors and accomodation of the reporter assay to screening of endocrine disrupters.
Molecular Mechanism of Transcriptional Activation Mediated by Steroid Hormone Receptors
The classical mechanism of action of steroid hormone receptors Steroid hormone receptors are sequence-specific DNA binding proteins with a common domain structure, and are categorized into the nuclear receptor superfamily 11, 12) . The typical protein structure of steroid hormone receptors is depicted in Fig. 1A . The N-terminal segment and the Cterminal half of the receptors are domains engaged in transcriptional activation. The C-terminal activation domain further includes segments necessary for ligand binding and for the interaction with other proteins, such as coactivators and hsp90 (heat-shock protein 90). A DNA binding domain composed of two zinc finger motifs is located between the two activation domains.
The consensus sequences to which each receptor binds are termed estrogen responsive element (ERE), androgen responsive element (ARE) and so on (Fig. 1B) . In all cases, they are comprised of inverted repeats of a specific hexanucleotide separated by three nucleotides. Receptors for progesterone (PR), glucocorticoid (GR), mineral corticoid (MR) and androgen (AR) share the same elements (GRE/ PRE/ARE/MRE) 13) , which is different from ERE 14) . As has been expected from the palindromic structure of these elements, the steroid hormone receptors usually bind to the corresponding element as a homodimer 15) . Steroid hormone receptors are associated with hsp90 when they are in the unliganded inactive state. When a ligand molecule binds to the corresponding hormone receptors, hsp90 dissociates, and the structural change occurs in the transcriptional activation domain of the receptors, leading to the dimer formation followed by binding to the target sequences. These receptors recruit coactivators, such as SRC (steroid receptor coactivator) family proteins or CBP (CREB binding protein), which loosen the chromatin structure by their histone acetyl transferase activities to allow access of the general transcription machinery to the promoter 16) .
Mechanisms underlying diversity of hormonal actions
Although the scheme of transactivation by steroid hormone receptors seems to be relatively simple, actual hormonal actions are fairly complex; many genes are up-or downregulated by the receptors in a tissue-and cell-type specific manner. One of the reasons underlying such complexity is thought to be the differential expression of the hormoneresponsive machinery including the receptors, coactivators and corepressors among cell species. In addition, hormone receptors can form a heterodimer with other transcription factors such as AP-1 17, 18) and Sp1 19) , and can stimulate transcription via the binding sequence of the partner. For instance, it has been reported that there are differences between two ER subtypes, ERα and ERβ, in tissuedistribution [20] [21] [22] and in the ability to recruit some coactivators in response to various xenoestrogens 23) . More interestingly it is reported that synthetic antiestrogens, tamoxifen, raloxyfen and ICI164384, give rise to opposite actions of ERα and ERβ, when these ER subtypes act as a complex with AP-1 17, 18) . That is, these chemicals exert the estrogenic action through the EREβ/AP-1 complex, whereas they exhibit the opposite effect through the EREα/AP-1 complex 24) . Such different responses of the two ER subtypes to estrogen-like substances, together with the difference in tissue-distribution, may contribute to the broad spectrum of estrogen actions.
Promoter context is another important determinants of the direction and/or the magnitude of gene expression, which is probably due to interactions between the receptors and other transcription factors. In this regard, the mechanism of the antiestrogenic action of TCDD is noteworthy. In the regulatory region of the estrogen-inducible cathepsin D gene for lysosomal protease, one of the ER responsive sequence comprises the ERE half site, the Sp1 site and XRE (xenobiotic responsive element), the target site of AhR. The ER/Sp1 complex is responsible for transcriptional activation through this region. When cells were cotreated with 17β-estradiol (E2) and TCDD, AhR activated by TCDD binds to this composite site and prevents the DNA binding of the ER/ Sp1 complex, resulting in the inhibition of E2-dependent transactivation of the cathepsin D gene 25) . The same process was also demonstrated in the other estrogen-inducible gene promoters, pS2 (a cell-proliferation related gene) 26) , c-fos 27) and hsp 27 28) .
Importance of Gene Expression Assay for Endocrine Disrupters
Other than direct interactions with the transcriptional machinery, chemicals can indirectly disrupt the endocrine system by modifying the production, secretion, storage or transport of hormone molecules. For example, TCDD reportedly exerts the antiestrogenic action through a pathway other than that described above. More specifically, CYP1A1 induced by TCDD, which is involved in the metabolism of E2, decreases the E2 level 29, 30) . Therefore, certain evidence for hormone-mimetic effects of chemicals should be obtained by detecting end-point manifestations in vivo, such as uterine hypertrophy or vaginal cornification which is normally induced by estrogen. Nevertheless, in the research of endocrine disrupters, major concerns have been focused on the chemicals that directly interact with hormone receptors, and actually many substances have been reported to act as agonists/antagonists of hormone receptors. In consequence, it has been expected that reliable assays for gene expression would be developed as screening methods to assess the biological effects of hormone mimetic substances.
Gene Expression Assays for Assessment of Biological Effects of Chemicals
A straightforward assessment of effects of chemicals on gene expression is to measure the induction of hormoneinduced proteins. Induction of vitellogenin, the progesterone receptor, pS2 and cathepsin D are well-known markers of the estrogenic action of chemicals 2, 5) . For the measurement of their induction level, well-established methods are available; such as Western blot analysis or ELISA (enzyme linked immunosorbent assay) for proteins, and Northern blot analysis or reverse transcription polymerase chain reaction (RT-PCR) for mRNA. Although these endogenous markers can be applicable to research on wild animals 31, 32) , their inductions are cell-and organ-specific, and laborious sample preparation or specific antibodies are necessary. Therefore measurement of these markers is inappropriate as a screening tool for a large number of chemicals.
Instead of measuring these endogenous markers, a transient transcription assay termed the reporter assay, has become the major choice for in vitro screening of endocrine disrupters. The essential item in this assay is a plasmid construct carrying a reporter gene fused to a regulatory region of a hormoneregulated gene (Fig. 2) . The reporter gene construct, when introduced into the cultured cells, is regulated in a hormonedependent fashion mediated by an endogenous or exogenously expressed receptor. Therefore, chemicals that act as an agonist of a receptor can induce reporter protein, and an antagonistic action of chemicals can also be assessed as an inhibitory effect on the reporter expression induced by a well-characterized agonist. Consequently, the reporter assay can provide insights into the mode of action of chemicals. In addition, the assay is fairly sensitive to the extent that the subtle difference in serum estrogen levels between prepubertal boys and girls can be demonstrated, which is equivalent to a nearly 100-fold higher sensitivity relative to radioimmunoassays 33) . Another remarkable merit of this strategy is that the assay can be accommodated easily to a variety of receptors by exchanging the regulatory region located upstream of the reporter gene. By virtue of this wide-ranging applicability of the reporter assay, McLachlan has proposed "functional toxicology" that provides a novel classification of chemicals based on their effects on various receptors, not based on their chemical characteristics 34) .
General Principle of the Reporter Assay
Three important components should be integrated in the reporter plasmid: the reporter gene, the minimal promoter containing the TATA box to which general transcription factors bind and the transcriptional regulatory sequence that confers hormone-dependent inducibility on the promoter (Fig.  2) .
Frequently used reporter genes include cat for E. coli chloramphenicol acetyl transferase (CAT), and lacZ for E. coli β-galactosidase (β-GAL). The firefly luciferase gene is now preferred because of its high sensitivity compared with that of other reporter enzymes, but β-GAL is the major reporter in the assay with yeast cells. Although the expression levels of these genes can be measured by each enzyme activity, measuring their protein levels by ELISA is also available if a high-throughput analysis is intended.
As the regulatory sequence, the upstream region of hormone responsive genes is available. For example, the mouse mammary tumor virus (MMTV) promoter is convenient for this purpose, because it includes both the minimal promoter and multiple binding sites for GR/MR/ PR 35, 36) . Such a regulatory fragment is usually several hundred nucleotides in length, and includes various elements other than the receptor binding site of interest, so that the possible effects of other signaling pathways should be taken into consideration.
Instead of a long promoter region containing a complex array of various elements, chemically synthesized hormone responsive elements can be inserted upstream of the reporter gene. In this case, the minimal promoter sequence should be selected separately, and that from the herpes simplex virus thymidine kinase (HSV-Tk) gene is frequently used for this purpose. Inserted hormone responsive elements are often multimerized to potentiate the response. More than two copies are necessary for PRE/GRE/ARE/MRE 13, 37) , but one copy of ERE has been reported to be adequate for transcriptional activation 14) . The ERE sequence of the xenopus vitellogenin A2 gene 14) is a standard in ERE-reporter plasmids, which is perfectly matched to the ERE consensus, and the widely adopted PRE/GRE/ARE/MRE sequence is that of the rat tyrosine aminotransferase gene 13) . The strategy based on the hormone responsive element is extremely advantageous, because a series of reporter plasmids corresponding to various receptors can be obtained by simply replacing the oligonucleotide cassette.
Since transcriptional activation mediated by receptors requires participation of multiple protein factors, it is important to use cell lines expressing these factors adequately. The human breast cancer cell line MCF-7 is known to provide the factors necessary to respond to estrogen, and is a frequently used cell line for screening of (anti)estrogenic substances. Co-transfection of an expression vector for a hormone receptor has an advantage in augmenting the receptor-specific responses of the reporter gene. The exogenous expression of a receptor molecule can also circumvent the limitations of the cell lines used, and enables the selection of the best combination of cell species and transfection methods, which is important in order to achieves high transfection efficiency.
Adaptation of the Reporter Assay to Assessment of Biological Effects of Chemicals

Screening methods for endocrine disrupters
To cope with the growing number of man-made chemicals, in vitro assay systems should be sensitive, short-termed, economical and applicable to high-throughput analysis. A Fig. 2 . Structure of the reporter plasmid. The figure is based on the use of synthetic hormone responsive elements (HRE), but the promoter and HRE can be replaced by the upstream regulatory region of hormone-inducible genes. Agonistic chemicals can induce reporter protein via HRE, and those with antagonistic action suppress reporter expression. As described in the text, chemicals can also indirectly affect the reporter expression via other pathways.
reporter assay using mammalian cells is generally not suitable for this purpose, because of the need for maintenance of cell lines, optimization of transfection conditions and expensive reagents for cell culture and transfection. Based on the observation that ER expressed in yeast cells is indistinguishable from that expressed in human cells in the response to estrogen 38) , the yeast-based reporter assay has been developed as a rapid, sensitive and economical method [39] [40] [41] . Saccharomyces cerevisiae is a commonly used yeast strain, and is transformed with an expression vector of hormone receptors and a reporter plasmid carrying lacZ under the control of a hormone responsive element. It has been reported that the detection limit of and responsiveness to E2 of the yeast-based assay are superior to those observed with a mammalian cell system 42) . Although the yeast-based assay is valuable as a primary screening system for hormonemimetic substances, results obtained by this assay are not necessarily parallel to those obtained by the assay with mammalian cells, which is probably derived from disparity between yeast and mammalian cells in cell permeability and metabolic capability and so on. Furthermore, a frequently encountered problem with the yeast-based assay is the inability to discriminate between agonists and antagonists 39, 41) . For example, estrogen receptor antagonists, such as ICI 164.384, ICI 182.780 and tamoxifen, act as agonists in the system, and the antagonistic effects of these chemicals are hardly detected 39) . A similar situation has also been observed in the assay for the androgen receptor 39) . The reason for this phenomenon has not yet been clarified.
To assess antagonistic effects of chemicals, an assay system based on mammalian cells is demanded. Maness et al. has reported the assay system for antagonists of the androgen receptor using the human hepatoma cell line, HepG2, which is transfected with both the luciferase reporter plasmid driven by the MMTV promoter and an expression vector for the androgen receptor 43) . In Hep G2 cells, the reporter gene is not expressed unless the androgen receptor is coexpressed. Luciferase activity induced by dihydrotestosterone (10 -7 M) was inhibited by DDT isomers and methoxychlor, demonstrating the effectiveness of this system in detecting the antagonistic effects of chemicals on the androgen receptor.
A high-throughput screening method with mammalian cells has been reported by Vinggaard et al., featuring a nonliposomal transfection reagent FuGene6 (available from Rosch Biochemicals) 44) . By virtue of the non-toxic nature of the reagent against chinese hamster ovary (CHO) cells and MCF-7 cells, the tedious medium change after transfection can be eliminated from the experimental procedure, and the culture can be scaled down to fit a microtiter plate. With this method antiandrogenic and estrogenic effects of various known chemicals have been demonstrated.
Other applications
Other than relatively simple applications of the reporter assay described above, more sophisticated modifications are possible for investigating the mechanistic aspects of the actions of chemicals as follows.
To demonstrate a specific interaction between chemicals and ER, an assay with a chimeric receptor molecule has been developed 42, [45] [46] [47] , in which the C-terminal liganddependent activation domain of ER is fused to the DNA binding domain of yeast transcription factor GAL4. This artificial chimeric receptor molecule retains the ligandspecificity, and it can give rise to transactivation via the GAL4 binding sequence located upstream of the reporter gene. With this chimeric reporter assay, Fielden et al. demonstrated that para-hydroxylated and para-chlorinated PCB congeners, whose affinity for AhR is known to be negligible, elicited the ER-mediated response 48) . A novel technique has recently been developed by modifying the reporter assay to detect chemicals exerting inhibitory effects on aromatase. Aromatase, one of the cytochrome P450 enzymes, converts androgen into estrogen, and is suspected of being involved in the mechanism of endocrine disrupters, because the inhibition of this enzyme results in a decreased level of estrogen. An assay system for aromatase inhibitors has recently been reported by Mak et al. 49) . To detect aromatase inhibitors, yeast cells are transformed with three plasmids: reporter plasmid regulated by ARE/PRE/GRE and two expression vectors for human aromatase and for the mouse androgen receptor. This triple transformant cannot express a reporter gene in response to an aromatizable androgen such as androstenedione, due to actions of the over-expressed aromatase. Expression of the reporter gene occurs when a test chemical cotreated with androstenedione inhibits aromatase so that the inhibitory effects of chemicals on aromatase can be evaluated by measuring the expression of a reporter gene.
Conclusions
Through research on endocrine disrupters, the importance of the gene expression system has been recognized as a target of chemicals, and the reporter assay has become a major screening method in this field. Since the assay can easily be modified to adapt to high-throughput analysis, it is expected to be developed into a useful primary screening Industrial Health 2002, 40, 113-120 system for evaluating the potentially hazardous effects of chemicals. In this context, the DNA micro array technique is probably the next generation assay. This method can screen thousands of genes at the same time to know which gene is active or depressed. Therefore, the profile of gene expression obtained may predict the status and fate of cells tested, and make possible the classification of effects of chemicals into novel categories, if the information on gene profiles specific to chemical exposures were to be accumulated. Although the information obtained from micro array analysis is speculative with regard to the mechanism of action of chemicals, it is a powerful tool for discovering novel marker genes as toxicity indicators of chemicals. A systematic combination of these gene expression assays is expected to serve as a hazard assessment of industrial chemicals.
